Cargando…

Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE study

In phase one of the REALIZE study, zolmitriptan nasal spray demonstrated a significant headache response from 10 min post–dose and total symptom relief from 30 min post–dose. The objective of phase two was to investigate patients' dosing patterns, satisfaction and preference following openlabel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gawel, M., Aschoff, J., May, A., Charlesworth, B. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2005
Materias:	Original
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3452072/ https://www.ncbi.nlm.nih.gov/pubmed/16362714 http://dx.doi.org/10.1007/s10194-005-0237-3

Ejemplares similares

Efficacy of zolmitriptan nasal spray in management of acute migraine
por: Bhattacharyya, Ramesh, et al.
Publicado: (2012)

Zolmitriptan nasal spray provides fast relief of migraine symptoms and is preferred by patients: a Swedish study of preference in clinical practice
por: Dahlöf, Carl G. H., et al.
Publicado: (2004)

Assessment Of Spanlastic Vesicles Of Zolmitriptan For Treating Migraine In Rats
por: El-Nabarawy, Nagla Ahmed, et al.
Publicado: (2019)

Efficacy of ADAM Zolmitriptan for the Acute Treatment of Difficult‐to‐Treat Migraine Headaches
por: Tepper, Stewart J., et al.
Publicado: (2019)

Formulation and Evaluation of Chitosan-Chondroitin Sulphate Based Nasal Inserts for Zolmitriptan
por: Kaur, Kirandeep, et al.
Publicado: (2013)

Long term safety, tolerability, and efficacy of intracutaneous zolmitriptan (M207) in the acute treatment of migraine
por: Nahas, Stephanie J., et al.
Publicado: (2021)

Nasal spray (Zavegepant) for migraines: a mini-review
por: Larik, Muhammad Omar, et al.
Publicado: (2023)

Myocardial infarction after taking zolmitriptan.
por: Pacheco-Coronado, Roberto, et al.
Publicado: (2005)

Preparation and evaluation of sublingual tablets of zolmitriptan
por: Prajapati, Shailesh T, et al.
Publicado: (2014)

Frovatriptan versus zolmitriptan for the acute treatment of migraine: a double-blind, randomized, multicenter, Italian study
por: Tullo, Vincenzo, et al.
Publicado: (2010)

Intranasal Zolmitriptan-Loaded Bilosomes with Extended Nasal Mucociliary Transit Time for Direct Nose to Brain Delivery
por: El Taweel, Mai M., et al.
Publicado: (2021)

Zavegepant nasal spray for the acute treatment of migraine: A meta analysis
por: Waqas, Muhammad, et al.
Publicado: (2023)

Improved migraine management in primary care: results of a patient treatment experience study using zolmitriptan orally disintegrating tablet
por: SHAPERO, G, et al.
Publicado: (2006)

Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian study
por: Tullo, Vincenzo, et al.
Publicado: (2012)

Randomized, double-blind, placebo-controlled, parallel-group, multi-center study of the safety and efficacy of ADAM zolmitriptan for the acute treatment of migraine
por: Spierings, Egilius LH, et al.
Publicado: (2017)

A New Stability Indicating HPLC Method for Related Substances in Zolmitriptan
por: Vijayakumar, E. K. S., et al.
Publicado: (2010)

Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan
por: Allais, Gianni, et al.
Publicado: (2011)

Preclinical support for the therapeutic potential of zolmitriptan as a treatment for cocaine use disorders
por: Garcia, Raul, et al.
Publicado: (2020)

Zavegepant nasal spray for the acute treatment of migraine: A Phase 2/3 double‐blind, randomized, placebo‐controlled, dose‐ranging trial
por: Croop, Robert, et al.
Publicado: (2022)

Liposomal Nasal Spray versus Guideline-Recommended Steroid Nasal Spray in Patients with Chronic Rhinosinusitis: A Comparison of Tolerability and Quality of Life
por: Eitenmüller, Anna, et al.
Publicado: (2014)

Effect of Skin Model on In Vitro Performance of an Adhesive Dermally Applied Microarray Coated with Zolmitriptan
por: Ameri, Mahmoud, et al.
Publicado: (2018)

On the Use and the Abuse of Nasal Sprays
por: Roy, Dunbar
Publicado: (1901)

Treatment of Allergic Rhinitis with Ectoine Containing Nasal Spray and Eye Drops in Comparison with Azelastine Containing Nasal Spray and Eye Drops or with Cromoglycic Acid Containing Nasal Spray
por: Werkhäuser, Nina, et al.
Publicado: (2014)

Zolmitriptan: A Novel Portal Hypotensive Agent Which Synergizes with Propranolol in Lowering Portal Pressure
por: Reboredo, Mercedes, et al.
Publicado: (2013)

Formulation development and evaluation of zolmitriptan oral soluble films using 2(2) factorial designs
por: Koteswari, Poluri, et al.
Publicado: (2016)

Tolerability and effects on quality of life of liposomal nasal spray treatment compared to nasal ointment containing dexpanthenol or isotonic NaCl spray in patients with rhinitis sicca
por: Hahn, C., et al.
Publicado: (2013)

Virucidal gargling and virucidal nasal spray
por: Kramer, Axel, et al.
Publicado: (2021)

Nasal Sprays: What Apparatus to Use
por: Brown, George
Publicado: (1894)

202 Treatment Satisfaction with Sublingual Immunotherapy in a Real-Life Setting
por: Hadler, Meike, et al.
Publicado: (2012)

Quality by Design Approach for Preparation of Zolmitriptan/Chitosan Nanostructured Lipid Carrier Particles – Formulation and Pharmacodynamic Assessment
por: Awadeen, Randa Hanie, et al.
Publicado: (2020)

DFN-02, Sumatriptan 10 mg Nasal Spray with Permeation Enhancer, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Study Assessing Functional Disability and Subject Satisfaction with Treatment
por: Lipton, Richard B., et al.
Publicado: (2019)

The Potential Synergistic Activity of Zolmitriptan Combined in New Self-Nanoemulsifying Drug Delivery Systems: ATR-FTIR Real-Time Fast Dissolution Monitoring and Pharmacodynamic Assessment
por: Abd El-Halim, Shady M, et al.
Publicado: (2021)

Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer
por: Pointreau, Yoann, et al.
Publicado: (2020)

Risk of contamination of nasal sprays in otolaryngologic practice
por: Aydin, Erdinc, et al.
Publicado: (2007)

The effect of xylometazoline spray for expansion of nasal cavity
por: Han, Jun-Sung, et al.
Publicado: (2013)

Stability of extemporaneously compounded amiloride nasal spray
por: Yellepeddi, Venkata, et al.
Publicado: (2020)

A comparison of preference for and efficacy of tablet formulations of sumatriptan (50 mg and 100 mg), naratriptan (2.5 mg), rizatriptan (10 mg), and zolmitriptan (2.5 mg) in the acute treatment of migraine
por: Dahlöf, Carl, et al.
Publicado: (2004)

Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life
por: Amoozegar, Farnaz, et al.
Publicado: (2009)

Real-world approach to managing dysgeusia following the use of esketamine nasal spray: a case report
por: Bossaller, Nicholas A., et al.
Publicado: (2020)

Towards realization of longer life
por: Khavinson, Vladimir, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lmajbdutpbc6cng4bp6mamv9fj